TerminatedInterventionalPhase 1Last updated Nov 25, 2020

Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease

Overview

ClinicalTrials.gov ID: NCT01522716
Lead Sponsor: Karolinska InstitutetOTHER
Brief Summary: The aim of the study is to evaluate the safety and efficacy of mesenchymal stromal cells as treatment for steroid-refractory chronic graft-versus-host disease.
Study Type: Interventional

Status

Study Record Dates

NCT02291770Unknown status

Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells

NCT01589549Unknown status

Mesenchymal Stromal Cells for Acute Graft Versus Host Disease

NCT04692376Unknown status

MSC for Treatment of cGVHD After Allo-HSCT

NCT00314483Unknown status

Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease

NCT02055625Withdrawn

Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease

NCT00972660Unknown status

Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease